Automated Peptide Synthesiser Platform introduced

The PurePep™ Chorus from Gyros Protein Technologies AB is a next-generation automated peptide synthesis platform. The new scalable instrument and software platform enables production of even the most challenging sequences at the highest possible crude purity and yield.
 
Scientists using peptides in development of novel therapeutics, biological research, or biomaterials development frequently work on long and difficult sequences, including modified cyclic peptides. These are particularly challenging to synthesise at sufficiently high purity and yield, and often require precious or expensive reagents.
 
Designed to overcome these issues and make these advancements accessible to both academic and industrial scientists, PurePep Chorus has a modular design, enabling in-lab upgrades aligned with the growing needs of peptide researchers. The flexible system can be purchased with, or lab-upgraded to include, two, four, or six channels, with independent induction heating, and real-time UV monitoring on two or more channels, depending upon researchers’ needs and budgets.
 
PurePep Chorus also employs flexible programming and Single-Shot™ additions, to eliminate the need for priming while minimising waste when using special amino acids and reagents. The instrument incorporates an intuitive interface software that simplifies the chemist’s workflows, accelerates set-up with pre-programmed methods, while also being designed for 21 CFR part 11 compliance.
 
Jasmine Gruia-Gray, SVP Marketing, Gyros Protein Technologies, said: “This latest instrument harnesses the power of our proprietary PurePep Pathway in a modular design, maximising purity and providing industry-leading productivity and flexibility. The new software has many new features, including the ability to program the next synthesis while the instrument is running.”